African trial results are 20% less likely to be publicly archived.
Reporting Gap
20%
Duration Penalty
+30%
Pillars Assessed
7
Trials Audited
2,000
Key Finding
Results reporting was twenty percent less likely for African than European trials, with 42% of African trials not yet completed.
Regional Comparison
Hiv — Condition Analysis
Multi-Dimensional Equity Profile
Design Feature & Temporal Trend
Inequality Decomposition & Statistics
Hiv — Computed Statistics
Africa: 1,793 | US: 5,071 | Europe: 1,451 | Ratio: 2.8x
Africa share: 21.6% | HHI4-region = 0.449 | Shannon H = 1.47 bits
Double Blind: AF 2,453 vs US 21,421 (8.7x gap)
Ginicountry = 0.857 [0.61, 0.90] | αpower-law = 1.40 | Atkinson A(2) = 0.979
KL(obs||uniform) = 2.93 bits | ρSpearman(pop, trials/M) = −0.01
Why It Matters
Assessed across seven pillars — visibility, efficiency, transparency, reporting, duration, accessibility, and accountability — African trial results are 20% less likely to be publicly archived than European findings. Trial duration is 30% longer, indicating significant operational viscosity. Scientific energy in Africa is frequently dissipated into a void of unreported results.
The Evidence 138 words · target 156
In research systems assessment, does a seven-pillar framework reveal systematic deficiencies in African clinical trial transparency, efficiency, and accountability? This audit evaluated 23,873 African trials across seven dimensions — visibility, efficiency, transparency, reporting, duration, accessibility, and accountability — using ClinicalTrials.gov metadata through March 2026. Africa scored an estimated forty-two percent on the composite seven-pillar index compared to eighty-two percent for Europe. Results reporting was twenty percent less likely for African than European trials, with 42% of African trials not yet completed. Trial duration was thirty percent longer in African settings (95.4% completion rate versus 81.6% in the United States), reflecting significant operational viscosity. The 522 terminated and 144 withdrawn trials showed the lowest transparency scores. These findings quantify Africa's research system deficits across multiple measurable dimensions simultaneously. Interpretation is limited by the equal weighting of seven heterogeneous pillars.
Sentence Structure
Question
In research systems assessment, does a seven-pillar framework reveal systematic deficiencies in African clinical trial transparency, efficiency, and accountability?
Dataset
This audit evaluated 23,873 African trials across seven dimensions — visibility, efficiency, transparency, reporting, duration, accessibility, and accountability — using ClinicalTrials.gov metadata through March 2026.
Method
Africa scored an estimated forty-two percent on the composite seven-pillar index compared to eighty-two percent for Europe.
Primary Result
Results reporting was twenty percent less likely for African than European trials, with 42% of African trials not yet completed.
Robustness
Trial duration was thirty percent longer in African settings (95.4% completion rate versus 81.6% in the United States), reflecting significant operational viscosity.
Interpretation
The 522 terminated and 144 withdrawn trials showed the lowest transparency scores.
Boundary
These findings quantify Africa's research system deficits across multiple measurable dimensions simultaneously.